sgRNA and gene vector for inhibiting bladder cancer by targeting human lncRNA-UCA1 and application of sgRNA

A gene carrier, the technology of pgl3-u6-uca1sgl, is applied to the sgRNA targeting human lncRNA-UCA1 to inhibit bladder cancer, the gene carrier and its application field, which can solve the problems of easy drug resistance, easy recurrence of patients, obvious side effects, etc. , to achieve the effect of inhibiting tumor growth, high knockout efficiency and simple steps
CN106399306AActive Publication Date: 2017-02-15THE FIRST AFFILIATED HOSPITAL OF XIAN JIAOTONG UNIV
3 Cites 37 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Applications(China)
Current Assignee / Owner
THE FIRST AFFILIATED HOSPITAL OF XIAN JIAOTONG UNIV
Publication Date
2017-02-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides sgRNA and a gene vector for inhibiting bladder cancer by targeting human lncRNA-UCA1 and an application of the sgRNA; specifically, sgRNA sequences of an lncRNA-UCA1 gene and a PD-1 gene suitable for CRISPR-Cas9 targeted splicing are designed; by transforming plasmids of specific splicing lncRNA-UCA1 gene and CRISPR-Cas9 nuclease gene into human bladder cancer cells, the expression of the lncRNA-UCA1 gene drops so as to inhibit the growth of tumor cells; and the plasmid, together with a human PD-1 gene targeted knockout vector, is transformed into a humanized mouse model of bladder cancer transplanted tumor, so as to obviously inhibit the growth of tumors. According to the invention, the vector is simple in preparing steps, the sgRNA is good in targeting property and the CRISPR-Cas9 is high in knockout efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of genetic engineering and biomedicine, and relates to the innovative design of CRISPR / Cas9 specific modification of human long-chain non-coding RNA (lncRNA)-UCA1 and multiple gene targets of PD-1, through targeted knockout of the expression of lncRNA UCA1 Inhibiting the growth of bladder cancer cells, combined with the application of immune gene (PD-1 / PDL-1) therapy strategy can enhance the therapeutic effect of bladder cancer, which is a new strategy of targeting immune gene therapy for bladder cancer. Background technique

[0002] In recent years, genome editing tools have been widely used in the field of biomedicine, which can change the expression of target genes, elucidate the function of genes, and try to treat clinical diseases. Among them, clustered regularly interspaced short palindromic repeats (CRISPR) technology can quickly, easily and efficiently target any gene in the genome, and has the advantages of e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More